INTRODUCTION
The bovine mitochondrial inhibitor protein inhibits the activity of free and membrane-bound F1-ATPase (Pullman & Monroy, 1963; Horstman & Racker, 1970) . Its physiological function is not yet established, but a regulatory role has been proposed (Pullman & Monroy, 1963; Asami et al., 1970; Ernster et al., 1973; van de Stadt & van Dam, 1974) . The protein is 84 amino acid residues long and its amino acid sequence has been reported by Frangione et al. (1981) . They found that the protein has a free N-terminus. In contrast, Dianoux et al. (1984) proposed that the N-terminal residue, glycine, is N-formylated, a post-translational modification described in only two other eukaryotic proteins (Fujiki et al., 1970; Lubke et al., 1971) . In common with other mitochondrial proteins encoded in nuclear DNA, the inhibitor protein is synthesized on cytoplasmic ribosomes as a longer precursor with an N-terminal extension (Schatz & Butow, 1983; Hay et al., 1984) . This extension directs the protein into the mitochondrion and is removed in the import process. Were the mature protein to be a-N-formylated, this modification would take place subsequent to processing and might be an integral part of import. We have re-investigated the structure of the N-terminal region of the inhibitor. We find in three independently isolated samples that the N-terminus of the protein is frayed, with sequences commencing at residues 1, 2 and 3. These various forms are sufficient to account for all chains in the preparations; no evidence can be found for an a-N-formylated protein. This is the fourth of seven imported bovine mitochondrial ATP synthase subunits so far investigated that has a frayed N-terminus (Walker et al., 1985) .
MATERIALS AND METHODS Chemicals and reagents
Clostripain was purchased from Sigma Chemical Co., Poole, Dorset, U.K. The sources of other chemicals and reagents have been given previously (Walker et al., 1985) .
Preparation of the inhibitor
The inhibitor protein was isolated from bovine heart mitochondria as described by Frangione et al. (1981) . A second sample, kindly donated by Dr. H. S. Penefsky, was isolated independently by the same procedure. A third sample, generously given by Dr. D. A. Harris, was isolated by a different method (Gomez-Fernandez & Harris, 1978) . Protein chemical methods Inhibitor (20 nmol) was hydrolysed with clostripain for 3 h at room temperature with an enzyme/substrate ratio of 1: 70 (w/w). A buffer containing 45 mM-Tris (pH 7.4), 1 mM-CaCl2 and 2.5 mM-dithiothreitol was used both to activate the enzyme (2 h, 75°C) and for hydrolysis (Mitchell, 1977) . Conditions for trypsin digestion, subsequent peptide isolation by h.p.l.c., amino acid Vol. 235 The two versions of the sequence reported by Frangione et al. (1981) and Dianoux et al. (1984) analysis and sequence analysis in a spinning-cup sequencer have been described previously (Walker et al., 1985 (Bradley et al., 1982) . In the fractionated tryptic digest a number of peptides were homogeneous and could be identified unambiguously from their amino acid compositions and sequences (see Fig. 2 ). Others were simple mixtures. The components of the mixtures could be identified, as shown in Fig. 2 , by sequence analysis. One region of the fractionated digest, that eluted at about 9% acetonitrile (peaks 10-12 in Fig. 2) , contained a number ofpeptides. These peaks were individually re-chromatographed at pH 7.8 with 50 mM- (-----) . ammonium bicarbonate as starting buffer under conditions otherwise identical with those of the first fractionation. From peak 10 the peptides ESGDNVR (residues 3-9 of the protein) and SSAGAVR (residues 10-16) were obtained as homogeneous peptides (for positions of peptides in protein refer to Fig. 1 ). The identity of the former was established by Edman degradation and f.a.b. m.s. (see Table 2 ). From peak lI the peptides EQAEEER (residues 26-34) and LKQSEDDD (residues 77-84) were obtained pure, and in addition the latter peptide was obtained in a mixture with a third peptide. Sequence analysis showed unambiguously that Vol. 235 3 8 9 I L the third peptide was SESGDVNR (residues 2-9). Confirmation of this result was again obtained by f.a.b. m.s. (Table 2 ). Re-chromatography of the third peak (number 12 in Fig. 2) failed to resolve the two components. However, once again they could both be identified unambiguously by Edman degradation and by f.a.b. m.s. (Table 2 ). It should be noted that the peptides isolated cover the entire sequence of the inhibitor protein.
RESULTS
Moreover, no other peptides were isolated from the digest.
The fractionated clostripain digest was similarly analysed (Fig. 3) . It was found that cleavage had not been restricted to the C-terminal side of arginine residues, but peptide bonds following some lysine residues also had been hydrolysed. As in the tryptic digest, the components of all peaks could be assigned to specific regions of the inhibitor protein; again three peptides were identified, corresponding to residues 1-9, 2-9 and 3-9. Under the conditions employed in this experiment, these were eluted as a partially resolved group at about 20% acetonitrile (see Fig. 3 ). The peaks labelled 5-7 were collected in a single fraction, and the f.a.b. m.s. spectrum shown in Fig. 4 shows the presence of at least five ion clusters, with their most abundant ions at m/z 949, 920, 863, 776 and 647. When these peaks were collected in partially resolved fractions and run separately by f.a.b. m.s., the spectra (Fig. 5) showed that peak 5 contained protonated molecular ions (MH+) at m/z 949 and 776, peak 6 MH+ ions at m/z 920 and 863 and peak 7 an MH+ ion at m/z 647. This separation clearly shows that these are not fragment ions but a series of peptides that match the molecular masses for the peptides previously identified in a tryptic digest by Edman degradation and f.a.b. m.s. (Table 1) .
DISCUSSION
Two independent sets ofsequence analysis experiments, carried out on the intact inhibitor protein and on peptides obtained from two separate enzyme digestions, show that the ATPase inhibitor protein from bovine mitochondria has a frayed N-terminus. Chains starting at residues 1, 2 and 3 were identified in three independently isolated samples of the protein. The major form, with free N-terminal glycine, has been observed previously (Frangione et al., 1981) . Examination of two enzyme digests of the protein failed to provide any evidence for a form with an a-N-formyl group. All peptides could be identified as components of the known sequence. Three related peptides represent residues 1-9, 2-9 and 3-9. All have free a-amino groups. The identification of a-Nformyl-peptide (residues 1-9) reported previously depended upon an f.a.b. m.s. spectrum (Dianoux et al., 1984) . This contained peaks at m/z 948, 920, 863, 776 and 647. The peak at 948 was attributed to the MH+ of a-N-formyl-(residues 1-9) and the other peaks as fragment ions. In the present work a similar spectrum has been obtained with peaks with the same m/z except that a peak at m/z 949 was observed rather than at 948. This peak is the MH+ of the C-terminal peptide. The peaks at m/z 920, 863 and 776 are the MH+ ions of residues 1-9, 2-9 and 3-9 respectively, and not fragment ions, as shown by further h.p.l.c. separations of both a tryptic digest and a clostripain digest. The MH+ with Mr 647 could correspond to either residue 4-9 or the second tryptic fragment (residues 10-16). However, this peptide was clearly identified by Edman degradation to be the second tryptic fragment. This was confirmed by esterification of this peptide with methanolic 0.5 M-HCI. The MH+ Mr was shifted to 661 and not 675, indicating the presence of one carboxy group, as would be expected for the second tryptic fragment. These results thus limit the N-terminal starting points of the inhibitor protein to positions 1, 2 and 3.
Frayed N-terminals have also been observed in the a-, /J-and 6-subunits of the bovine mitochondrial F1-ATPase complex (Walker et al., 1985) . Two explanations can be advanced to explain their origin. Firstly, they may arise as artifacts by proteolysis during protein isolation or, secondly, they may be produced by inexact proteolytic processing during import of the proteins into the mitochondrion. That samples of F1-ATPase and inhibitor isolated in different laboratories and by different procedures are similarly frayed tends to argue against the first proposal. Closer study of the processing event is required to test the alternative hypothesis.
